Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756632
Evaluating the Effectiveness of an AI-powered Physician Assistant in Improving Patients' and Physician's Satisfaction in an Outpatient Setting of a Tertiary Care Hospital.Aga Khan UniversityNot Yet RecruitingNot Applicable
NCT07756632Not Yet Recruiting
Not Applicable
Evaluating the Effectiveness of an AI-powered Physician Assistant in Improving P...Aga Khan University
NCT07754227
Early Versus Delayed Ileostomy Closure Following Bowel Surgery: A Randomized Controlled TrialDr. Waseem UllahCompletedNot Applicable
NCT07754227Completed
Not Applicable
Early Versus Delayed Ileostomy Closure Following Bowel Surgery: A Randomized Con...Dr. Waseem Ullah
NCT07756346
A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis SuppurativaEmory UniversityNot Yet RecruitingPhase 2
NCT07756346Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradeniti...Emory University
NCT07754526
OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care Treatment Alone.Omeza, LLCNot Yet RecruitingNot Applicable
NCT07754526Not Yet Recruiting
Not Applicable
OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care T...Omeza, LLC
NCT07756138
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexStanford UniversityNot Yet RecruitingPhase 2
NCT07756138Not Yet Recruiting
Phase 2
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexStanford University
NCT07754344
Dural Medical Adhesive for Watertight Sealing in Dural RepairMedprin Regenerative Medical Technologies Co., Ltd.CompletedPhase 3
NCT07754344Completed
Phase 3
Dural Medical Adhesive for Watertight Sealing in Dural RepairMedprin Regenerative Medi...
NCT07754825
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic StrokeShanghai Pharmaceuticals Holding Co., LtdNot Yet RecruitingPhase 2
NCT07754825Not Yet Recruiting
Phase 2
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Isch...Shanghai Pharmaceuticals...
NCT07753863
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm Infants Needing Continuous Monitoring: the PRO-NEO-SKIN (Protect Neonatal Skin) Pilot StudyPaolo Manzoni Study GroupNot Yet RecruitingNot Applicable
NCT07753863Not Yet Recruiting
Not Applicable
Use of a Silicone Sensor to Protect Fragile Neonatal Skin in Moderately Preterm...Paolo Manzoni Study Group
NCT07755332
Association Between Central Sensitization and the Root Mean Square of Successive DifferencesIstanbul Demiroglu Bilim UniversityCompleted
NCT07755332Completed
—
Association Between Central Sensitization and the Root Mean Square of Successive...Istanbul Demiroglu Bilim...
NCT07755033
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Multidimensional Health MarkersChinese Medical AssociationNot Yet RecruitingNot Applicable
NCT07755033Not Yet Recruiting
Not Applicable
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Mult...Chinese Medical Associati...
NCT07755943
An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health Markers - The BioAge TrialBiofortis Clinical Research, Inc.Recruiting
NCT07755943Recruiting
—
An Evaluation of Long-Term Supplement Use on Biological Age and Metabolic Health...Biofortis Clinical Resear...
NCT07754721
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health ImpactsHualien Tzu Chi General HospitalRecruitingNot Applicable
NCT07754721Recruiting
Not Applicable
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study...Hualien Tzu Chi General H...
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07754175
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a TrialKang Stem Biotech Co., Ltd.Recruiting
NCT07754175Recruiting
—
A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and...Kang Stem Biotech Co., Lt...
NCT07754279
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica HoldingCompletedPhase 1
NCT07754279Completed
Phase 1
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica Holding
NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerRevolution Medicines, Inc.Not Yet RecruitingPhase 1
NCT07756281Not Yet Recruiting
Phase 1
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pa...Revolution Medicines, Inc...
NCT07755150
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 DiabetesChendu DIAO Pharmaceutical Group CO., LTD.Not Yet RecruitingPhase 2
NCT07755150Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects Wi...Chendu DIAO Pharmaceutica...
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed4 (20%)
not_applicable8 (40%)
Phase 25 (25%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 31 (5%)